Ferguson Toby
SEC insider (Form 3/4/5 filer). CIK 0002015616. Chief Medical Officer at Voyager Therapeutics, Inc. (VYGR). 4 reported Form 4/5 transactions since Sep 2024; latest on Feb 6, 2026. Located in LEXINGTON, MA.
Companies Ferguson Toby has filed insider reports for
- Voyager Therapeutics, Inc. (VYGR): Officer, Chief Medical Officer
Ferguson Toby
CIK: 0002015616
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)2 (50.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (50.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
VYGR
Voyager Therapeutics, Inc.
Officer
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- Feb 6, 2026VYGR
Voyager Therapeutics, Inc.
AwardDirect45K shares- - Aug 18, 2025VYGR
Voyager Therapeutics, Inc.
SaleDirect19K shares at avg. $3.73$71K - Apr 2, 2025VYGR
Voyager Therapeutics, Inc.
SaleDirect10.1K shares at avg. $3.43$35K - Feb 21, 2025VYGR
Voyager Therapeutics, Inc.
AwardDirect63K shares-
1-4 of 4 transactions